LATEST ALERTS
Cannabinoids
United Nations commission votes to classify HHC as a prohibited substance
25th March 2025 - News analysis |
The United Nations Commission on Narcotic Drugs voted on 12th March to classify HHC as a banned substance, with an aim of restricting and controlling the use of the cannabinoid at an international level
Bill to ban synthetic cannabinoids in hemp products heads to governor…
24th March 2025 - Alerts | New Mexico, North America, United States |
EU environmental tracker, March 2025
21st March 2025 - Regulatory databases |
This tracker covers sustainability policy proposals affecting the cannabis and hemp-derived vape sector in the European Union and is updated every month.
Senate bill that would prohibit most hemp-derived cannabinoids moves to House…
20th March 2025 - Alerts | North America, Texas, United States |
An analysis of magistral preparations: a global regulatory overview
12th March 2025 - Regulatory reports |
This report examines the regulation of magistral preparations in many of the countries across the world that allow and regulate them
A look at the latest academic studies on cannabinoids and cannabis compounds
28th February 2025 - News analysis |
Knowledge about cannabinoids and other cannabis compounds continues to inch forward, but though most recent major reported studies have been positive, that has not universally been the case
House bill to expand legal definitions of cannabis goes to Senate…
28th February 2025 - Alerts | Hawaii, North America, United States |
Tamarind Intelligence podcast: what’s next for e-cigarette regulation?
24th February 2025 - Podcasts |
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
How might Trump’s confirmed nominees and his US DEA pick impact the industry?
18th February 2025 - News analysis |
Nomination of Terrance Cole as head of the US Drug Enforcement Administration (DEA) is unlikely to be great overall for either the cannabis or intoxicating hemp-derived cannabinoid (IHDC) industries
Tamarind Intelligence podcast: Global insights into novel nicotine regulation
14th February 2025 - Podcasts |
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
Embrapa to launch cannabis cultivation research programme…
13th February 2025 - Alerts | Brazil, South America |
Bill introducing new cannabinoid categories heads to Senate…
5th February 2025 - Alerts | North America, United States, Utah |
Do US cannabis companies need to resort to drastic measures to stay in business?
31st January 2025 - Blogs , News analysis |
Cannabis companies have been pushing the envelope of acceptable marketing and business practices by insinuating unproven benefits for their products while also looking to create the strongest goods possible
Regulatory brief: Brazilian high court legalises hemp
28th January 2025 - Regulatory reports |
The Brazilian Superior Court of Justice recently legalised hemp with up to 0.3% THC for medicinal and industrial purposes. This short report analyses this new ruling in detail
Global debate on HHC regulation heats up ahead of UN meeting on narcotic drugs
22nd January 2025 - News analysis |
As the 68th session of the United Nations (UN) Commission on Narcotic Drugs approaches in March 2025, the international debate over the regulation of hexahydrocannabinol (HHC) continues to gain momentum
Addiction experts oppose HHC prohibition…
20th January 2025 - Alerts | Czech Republic, Europe |
Delta-8 bill fails to pass despite Senate support…
8th January 2025 - Alerts | Illinois, North America, United States |
US rescheduling, Brazil’s hemp hopes, and the status quo for cannabis in 2025
8th January 2025 - News analysis |
Rescheduling of cannabis in the US will headline a somewhat slow slate of regulatory changes in 2025, CannIntelligence predicts, while much of the remaining positivity for cannabis revolves around the status quo being maintained
Recreational cannabis plans dashed, medical and IHDCs on the up in 2024
20th December 2024 - News analysis |
On the surface, 2024 could seem like a disappointing year for commercial cannabinoids, but scratch the surface and it really was not all that bad
Tamarind Intelligence podcast: 2024 highlights and 2025 predictions
19th December 2024 - Podcasts |
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Bill to ban sale of intoxicating hemp products unlikely to move forward…
17th December 2024 - Alerts | North America, Ohio, United States |
Spain: CBD and cannabis regulation, December 2024
13th December 2024 - Regulatory reports |
This report offers a detailed analysis of the current regulatory framework in place in Spain for hemp, CBD and other cannabinoids, as well medical and recreational cannabis
On the latest Trump picks for attorney general and to head FDA and agriculture
12th December 2024 - Blogs , News analysis |
The ever-changing make-up of US president-elect Donald Trump’s nominees for posts in his administration – still far from set in stone – offers a few new options that will impact on cannabis and hemp
Australian study finds objective scientific evidence that cannabis increases sleep
21st November 2024 - News analysis |
Cannabis may help sleep, according to Australian researchers who found evidence of the hypnotic properties of cannabinol (CBN) and say their study is the first to use objective measures to prove CBN increases sleep
Tamarind Intelligence podcast: Impact of novel nicotine products on public tobacco firms
13th November 2024 - Podcasts |
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
Regulatory brief: Czech Republic passes unique law on psychoactive substances
7th November 2024 - Regulatory reports |
President Petr Pavel recently signed into law an amendment to the Act on Addictive Substances that regulates “psychomodulating substances”. This short report analyses this new law in detail
Synthetic cannabinoids are added to narcotics list…
6th November 2024 - Alerts | Europe, Switzerland |
European recreational cannabis models and commercial opportunities
4th November 2024 - Regulatory reports |
This report examines the models of recreational cannabis legalisation that are currently being implemented in Europe, their nuances, and the commercial opportunities they may provide
ACMD supports proposal to raise maximum THC content in hemp…
30th October 2024 - Alerts | Europe, United Kingdom |
Tamarind Intelligence podcast: A look into the illicit vape market
16th October 2024 - Podcasts |
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
Proposed amendment to vape law includes ban on THC in e-liquids…
11th October 2024 - Alerts | Central America, Costa Rica |
Final rules on hemp products ban THCA flower…
8th October 2024 - Alerts | North America, Tennessee, United States |
Brazilian pharmaceutical company acquires Colombian cannabis giant
30th September 2024 - News analysis |
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
